Cord clamping
ProcedureUmbilical cord clamping after delivery.
NCT Number: NCT04351997
The investigators conducted a RCT (parallel group study with 1:1 randomisation) comparing ECC (at 60 seconds) and DCC (at 180 seconds) in 90 cases of normal birth by' two-step' delivery. In term infants born by' two-step' delivery, DCC results is a higher blood volume in the newborn and facilitates the maternal-placental-fetal exchange of circulating compounds, without potentially detrimental neonatal outcomes.
Looking for future studies?
Notify Me2 day–2 day
All sexes
Interventional
Not applicable
Policlinico Abano Terme, Abano Terme, Padua, Italy
Introduction: Placental transfusion supports an important blood transfer to the neonate, promoting a more stable and smooth transition from fetal to extra-uterine life with the potential to prevent iron deficiency in young children. Several studies have demonstrated that cord clamping timing is greatly relevant for facilitate placental transfusion, the transfer of extra blood from the placenta to the infant in the third stage of labor. Therefore, during natural 'two-step' delivery umbilical cord management may play a relevant role on blood passage to the neonate and it may affect neonatal hematological values and placental transfusion. The most effective way to manage umbilical cord in in 'two-step' delivery remains to be established.
Objective: The aim of the present study is to evaluate the effect of two different methods of umbilical cord management (Early Cord Clamping - ECC vs. Delayed Cord Clamping - DCC) on the placental transfusion, defined by in two-step delivery, by ∆ haematocrit (Hct) from arterial cord blood at birth and capillary blood at 48 h of age. Accounting for physiological body weight decrease. Secondary outcomes included contemporary estimate of blood gases, lactate, and glucose concentrations in arterial cord blood gas analysis.
Material and methods: This is a randomized clinical trial on the effect of different cord management newborns born by 'two-step' delivery. After obtaining parental consent, all mothers > 38 weeks' gestation will be assigned to either ECC or DCC group in a 1:1 ratio according to a randomized sequence generated by an opened, sealed, numbered, opaque envelope containing the cord clamping interventions allocation, ECC (at 1 minute) or DCC (at 3 minutes after delivery).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Vaginal delivery Gestational age >37 weeks Natural process of labor
Exclusion criteria
Cesarean section Fetal distress Major isoimmunisation Ccongenital diseases Cord abnormalities.
Umbilical cord clamping after delivery.
Time frame: Second day of life
We compared the effects of ECC and DCC on placental transfusion in two-step delivery, by ∆ haematocrit (Hct) from arterial cord blood at birth and capillary blood at 48 h of age.
Time frame: Second day of life.
Estimate of blood gases, lactate, and glucose concentrations in arterial cord blood gas analysis.
Time frame: First and second day of life
Neonatal body weight (Kg) and weight at discharge (Kg)
Time frame: At birth
pH (units)
Time frame: At birth
mmol/L
Time frame: At birth
mg%
Policlinico Abano Terme
Other
Early and Delayed Cord Clamping in Infants Born by 'Two-step' Vaginal Delivery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02671305
Anemia, Anemia, Neonatal
Bari, Italy
View Trial DetailsNCT03916159
Anemia, Anemia, Neonatal
Cologne, Germany
View Trial DetailsNCT04898868
Anemia, Anemia, Neonatal
Taipei, Taiwan
View Trial DetailsNCT02478684
Anemia, Anemia, Neonatal
New York, United States
View Trial Details